Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Menicon Co ( (JP:7780) ) just unveiled an announcement.
Menicon Co., Ltd. announced it will record extraordinary losses due to structural reforms, including impairment losses on lens care product manufacturing equipment and expenses related to withdrawing from certain healthcare businesses. These actions are part of a strategic review to improve capital efficiency and focus on growth areas, such as orthokeratology and global expansion. Additionally, the company is restructuring its European operations to enhance efficiency and profitability, despite incurring temporary costs. Menicon has also revised its dividend policy to ensure stability, reflecting its commitment to long-term shareholder value.
More about Menicon Co
Menicon Co., Ltd. operates in the vision care industry, primarily focusing on the production and distribution of contact lenses and related products. The company is expanding its orthokeratology-related businesses and aims to strengthen its market presence, especially in Asia, including China.
YTD Price Performance: 5.23%
Average Trading Volume: 79
Technical Sentiment Signal: Buy
Current Market Cap: €666.6M
See more insights into 7780 stock on TipRanks’ Stock Analysis page.